387 results on '"Neut, C."'
Search Results
2. In-situ forming PLGA implants: Towards less toxic solvents
3. Film Coatings Based on Aqueous Shellac Ammonium Salt “Swanlac® ASL 10” and Inulin for Colon Targeting
4. In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release
5. In vitro evaluation of antibacterial activity of a plant extract-loaded wound dressing
6. Évaluation in vitro de l'activité antibactérienne d'un pansement chargé d'extraits de plantes
7. In-situ forming implants for dual controlled release of chlorhexidine and ibuprofen for periodontitis treatment: Microbiological and mechanical key properties
8. Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections
9. Hot melt extruded polysaccharide blends for controlled drug delivery
10. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?
11. Cyclodextrin modified PLLA parietal reinforcement implant with prolonged antibacterial activity
12. Robustness of Controlled Release Tablets Based on a Cross-linked Pregelatinized Potato Starch Matrix
13. Film Coatings Based on Aqueous Shellac Ammonium Salt “Swanlac® ASL 10” and Inulin for Colon Targeting.
14. Electrospun Filtering Membrane Designed as Component of Self-Decontaminating Protective Masks
15. Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance
16. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment
17. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance
18. How to easily provide zero order release of freely soluble drugs from coated pellets
19. In vivo efficacy of microbiota-sensitive coatings for colon targeting: A promising tool for IBD therapy
20. In situ forming implants for periodontitis treatment with improved adhesive properties
21. First report of the predominance of clonal complex 398 Staphylococcus aureus strains in osteomyelitis complicating diabetic foot ulcers: a national French study
22. Comparative study of vascular prostheses coated with polycyclodextrins for controlled ciprofloxacin release
23. Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole
24. Safety, Healing, and Efficacy of Vascular Prostheses Coated with Hydroxypropyl-β-cyclodextrin Polymer: Experimental In Vitro and Animal Studies
25. P602 Tofacitinib treatment prevents post-operative recurrence of Crohn’s Disease modeled by ileocecal resection in HLA-B27 transgenic rats
26. Cyclodextrin and maltodextrin finishing of a polypropylene abdominal wall implant for the prolonged delivery of ciprofloxacin
27. Methyl-β-cyclodextrin modified vascular prosthesis: Influence of the modification level on the drug delivery properties in different media
28. Antimicrobial effect and physical properties of an injectable \'active oxygen\' gel for the treatment of periodontitis
29. Antimicrobial activity of selected Iranian medicinal plants against a broad spectrum of pathogenic and drug multiresistant micro-organisms
30. In vitro study of a HPγ-cyclodextrin grafted PET vascular prosthesis for application as anti-infectious drug delivery system
31. Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics
32. Functionalization of PVDF membranes with carbohydrate derivates for the controlled delivery of chlorhexidin
33. Un espoir pour le traitement des infections ostéo-articulaires : les éponges à base de chitosan/polymère de cyclodextrines
34. Dysbiosis in inflammatory bowel disease
35. Local appendiceal dysbiosis: the missing link between the appendix and ulcerative colitis?
36. Adsorption and Effectiveness of Different Antibiotics on Pure Hydroxyapatite (HA) with Controlled Porosity
37. In-situ forming implants for the treatment of periodontal diseases: Simultaneous controlled release of an antiseptic and an anti-inflammatory drug
38. Fecal β-D-Galactosidase Production and Bifidobacteria Are Decreased in Crohn's Disease
39. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease
40. Dysbiosis as a prerequisite for IBD
41. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation
42. In vitro activity of gatifloxacin, a new fluoroquinolone, against 204 anaerobes compared to seven other compounds
43. Genetically related Escherichia coli strains associated with Crohnʼs disease
44. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces
45. P049 HLA B27 transgenic rat: a new animal model of ileitis post-surgery reproducing inflammatory bowel disease
46. Antiviral and antibacterial effects of 16 plants used in Ivorian traditional medicine
47. Antimicrobial and acetylcholinesterase inhibition activities of an endemic plant from Sahara: Myrtus nivellei Batt. & Trab. (Myrtaceae)
48. Antimicrobial properties of phenolic compounds from hops, Humulus lupulus L.: fight against multidrug resistance
49. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease
50. Chemical composition of the essential oil from Algerian Genista quadriflora Munby and determination of its antibacterial and antifungal activities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.